James Nathanielsz is the founder of Propanc. Propanc has raised $30M in total funding. Latest round: IPO. Based in Melbourne, Australia.
James Nathanielsz is the founder and Chief Executive Officer of Propanc Biopharma, Inc., a biopharmaceutical company specializing in pancreatic proenzyme therapies for metastatic cancer. He also holds multiple leadership roles, including Executive Chairman, CFO, and Treasurer, after founding the company in 2007. Nathanielsz has raised over $30 million for Propanc and led its uplisting to NASDAQ in August 2025.
Full founder directory · Investor directory · Company funding database · Fundraising library